We develop an innovative subcutaneous formulation for anticancer highly potent API to unlock their full potential.
IMESCIA is a preclinical-stage company developing a new formulation for anticancer highly potent APIs to unlock their full potential.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
NEFTYS Finance, Financial Services | NEFTYS Finance, Financial Services | Other 30 Nov 2023 | | |
CNRS Innovation Research, Research Services | CNRS Innovation Research, Research Services | Other 7 Mar 2024 | |